The majority of patients in our study group showed significant functional benefit from surgical resection of recurrent brain metastases. This contributes to a better quality of life in this patient group showing a short overall survival time
Background Brain metastases (BM) frequently cause focal neurological deficits leading to a reduced K...
BACKGROUND: While standards for the treatment of newly diagnosed glioblastomas exist, therapeutic re...
Background: Current treatment guidelines for stage IV non-small cell lung cancer (NSCLC) with brain ...
The majority of patients in our study group showed significant functional benefit from surgical rese...
Background Treatment decision for recurrent symptomatic brain metastases (BM) is challenging with sc...
OBJECTIVE Current guidelines primarily suggest resection of brain metastases (BMs) in patients with ...
BACKGROUND In patients with locally recurrent brain metastases (LRBMs), the role of (repeat) cran...
Background Brain metastases occur in 10%–40% of patients with cancer and are more common than primar...
Background Brain metastases (BM) are a common consequence of lung cancer and surgery is effective; h...
AbstractCombined resection of primary non-small-cell lung cancer and single brain metastasis is repo...
Brain metastases (BM) develop in about 30% of all cancer patients. Surgery plays an important role i...
Background. In patients with locally recurrent brain metastases (LRBMs), the role of (repeat) cranio...
Abstract Background Surgical resection of brain metastases improves symptoms and...
Background and objectivesBrain metastases occur in about 30% of all patients with non-small cell lun...
This systematic review aims to improve understanding of the burden of disease associated with brain ...
Background Brain metastases (BM) frequently cause focal neurological deficits leading to a reduced K...
BACKGROUND: While standards for the treatment of newly diagnosed glioblastomas exist, therapeutic re...
Background: Current treatment guidelines for stage IV non-small cell lung cancer (NSCLC) with brain ...
The majority of patients in our study group showed significant functional benefit from surgical rese...
Background Treatment decision for recurrent symptomatic brain metastases (BM) is challenging with sc...
OBJECTIVE Current guidelines primarily suggest resection of brain metastases (BMs) in patients with ...
BACKGROUND In patients with locally recurrent brain metastases (LRBMs), the role of (repeat) cran...
Background Brain metastases occur in 10%–40% of patients with cancer and are more common than primar...
Background Brain metastases (BM) are a common consequence of lung cancer and surgery is effective; h...
AbstractCombined resection of primary non-small-cell lung cancer and single brain metastasis is repo...
Brain metastases (BM) develop in about 30% of all cancer patients. Surgery plays an important role i...
Background. In patients with locally recurrent brain metastases (LRBMs), the role of (repeat) cranio...
Abstract Background Surgical resection of brain metastases improves symptoms and...
Background and objectivesBrain metastases occur in about 30% of all patients with non-small cell lun...
This systematic review aims to improve understanding of the burden of disease associated with brain ...
Background Brain metastases (BM) frequently cause focal neurological deficits leading to a reduced K...
BACKGROUND: While standards for the treatment of newly diagnosed glioblastomas exist, therapeutic re...
Background: Current treatment guidelines for stage IV non-small cell lung cancer (NSCLC) with brain ...
DOI
Add to ORKG